Blue Water Vaccines, Inc. (BWV)

NASDAQ: BWV · IEX Real-Time Price · USD
1.25
0.00 (0.00%)
At close: Feb 1, 2023, 12:00 AM
1.27
+0.02 (1.60%)
Pre-market: Feb 2, 2023, 9:22 AM EST
Market Cap 19.35M
Revenue (ttm) n/a
Net Income (ttm) -14.56M
Shares Out 15.48M
EPS (ttm) -1.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 71,426
Open 1.20
Previous Close 1.25
Day's Range 1.17 - 1.30
52-Week Range 0.91 - 90.90
Beta n/a
Analysts Buy
Price Target 5.61 (+348.8%)
Earnings Date Feb 9, 2023

About BWV

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The ... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Feb 18, 2022
Employees 5
Stock Exchange NASDAQ
Ticker Symbol BWV
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for BWV stock is "Buy." The 12-month stock price forecast is $5.61, which is an increase of 348.80% from the latest price.

Price Target
$5.61
(348.80% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates

CINCINNATI, Ohio, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to addr...

1 day ago - GlobeNewsWire

Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors

CINCINNATI, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address si...

2 weeks ago - GlobeNewsWire

Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco

CINCINNATI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address si...

3 weeks ago - GlobeNewsWire

Blue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives “Buy” Rating From Both

CINCINNATI, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address si...

1 month ago - GlobeNewsWire

Blue Water Vaccines Organizes Key Opinion Leader Event to Discuss Unmet Need for Acute Otitis Media and Pneumonia Vaccine and Its Streptococcus pneumoniae Vaccine Candidate

CINCINNATI, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”) a biopharmaceutical company developing transformational vaccines to address sig...

2 months ago - GlobeNewsWire

Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress West Coast 2022

CINCINNATI, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), today announced that Ali Fattom, Ph.D., will present at the World Vaccine & Im...

2 months ago - GlobeNewsWire

Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program

CINCINNATI, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), today announced its financial results for the third quarter ended September 30...

3 months ago - GlobeNewsWire

Blue Water Vaccines Announces Plans to Evaluate Efficacy of Streptococcus pneumoniae Vaccine Candidate Against Pneumococcal Pneumonia at the World Vaccine Congress in Barcelona

CINCINNATI, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address si...

4 months ago - GlobeNewsWire

Blue Water Vaccines to Present at World Vaccine Congress Europe 2022

CINCINNATI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address s...

4 months ago - GlobeNewsWire

Blue Water Vaccines to Present In Person and via Webcast at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

CINCINNATI, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address si...

5 months ago - GlobeNewsWire

Blue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom

CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address sig...

5 months ago - GlobeNewsWire

Blue Water Vaccines Announces Appointment of Retired Deloitte Consulting Senior Managing Director Simon Tarsh to Board of Directors

CINCINNATI, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address si...

5 months ago - GlobeNewsWire

Monkeypox vaccine plans lead to stock jump for Blue Water Vaccines

After announcing that it plans to potentially develop a monkeypox vaccine, Blue Water Vaccines shares are surging.

6 months ago - Yahoo Finance

BWV Stock Soars as Blue Water Vaccines Explores Monkeypox Vaccine

Source: angellodeco / Shutterstock.com Blue Water Vaccines (NASDAQ: BWV) stock is rocketing higher on Wednesday after the company announced it will explore the possibility of making a monkeypox vacci...

6 months ago - InvestorPlace

Blue Water Vaccines Announces Exploration of Its Virus-Like Particle (VLP) Platform for Use in Monkeypox Vaccine Candidate

CINCINNATI, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address si...

6 months ago - GlobeNewsWire

7 Short-Squeeze Stocks to Put on Your Must-Watch List

The beaten-down stock market has created an opportunity for contrarian investors in short-squeeze stocks. Essentially, bearish traders must borrow the underlying securities which they are pessimistic ...

Other symbols: EJHENVBKOSSSDIGSIGA
6 months ago - InvestorPlace

Blue Water Vaccines Reports Second Quarter 2022 Financial Results and Recent Business Highlights

CINCINNATI, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) today announced its financial results for the second quarter ended June 30, 202...

6 months ago - GlobeNewsWire

Blue Water Vaccines Announces Closing of $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules

CINCINNATI, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address si...

6 months ago - GlobeNewsWire

What Is Going on With Blue Water Vaccines (BWV) Stock Today?

Source: shutterstock.com/PhotobyTawat Blue Water Vaccines (NASDAQ: BWV) stock is jumping more than 50% today despite having no news to offer. Based in Cincinnati, the company works on vaccines for fl...

6 months ago - InvestorPlace

Blue Water Vaccines Announces Signing of Sponsored Research Agreement with Cincinnati Children's Hospital Medical Center for S&P Vaccine Platform Development

CINCINNATI, July 20, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address si...

7 months ago - GlobeNewsWire

Blue Water Vaccines to Present at the JMP Securities Life Science Conference

CINCINNATI, June 06, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address si...

8 months ago - GlobeNewsWire

Blue Water Vaccines Announces Collaboration with Instituto Butantan for the Development of BWV-101, a Universal Influenza Vaccine Candidate

CINCINNATI, May 19, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing vaccines, announces a collaboration with...

9 months ago - GlobeNewsWire

Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments

CINCINNATI, May 13, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), today announced its financial results for the first quarter ended March 31, 202...

9 months ago - GlobeNewsWire

Blue Water Vaccines Inc. to Present at H.C. Wainwright Global Investment Conference

CINCINNATI, May 12, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address sign...

9 months ago - GlobeNewsWire

5 Stocks Halted In Wednesday's Session: Here's Why

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bri...

Other symbols: CVNARKTU
9 months ago - Benzinga